Oriva Therapeutics
PrivateLast Round
Pre Seed
Jan 22, 2026
Company Overview
Oriva Therapeutics operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Pre Seed round in January 2026.
Oriva Therapeutics is a biotechnology company developing therapies for chronic gynecological diseases such as endometriosis and uterine fibroids.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oriva Therapeutics Comparables
Compare Oriva Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FimmCyte | 88% | |
| Gesynta Pharma AB | 87% | |
| Maipl Therapeutics | 86% |
For institutional investors. Book with your work email.
Oriva Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Oriva Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Pre Seed |
Oriva Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oriva Therapeutics's valuation, stock price, and market status.
Is Oriva Therapeutics a public or private company?
Oriva Therapeutics is a private company.
What is the current stock price of Oriva Therapeutics?
Oriva Therapeutics is a private company, so its shares have no public market price. Caplight tracks Oriva Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oriva Therapeutics worth (valuation)?
Valuation information for Oriva Therapeutics is not publicly available.
Can I buy Oriva Therapeutics stock?
Oriva Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oriva Therapeutics's last funding round?
Oriva Therapeutics's most recent funding round was Pre Seed on January 22, 2026.
Who are the main investors in Oriva Therapeutics?
Key investors in Oriva Therapeutics include Asabys Partners.
Will Oriva Therapeutics IPO soon?
No public IPO plans have been announced for Oriva Therapeutics.
How can I track Oriva Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Oriva Therapeutics's shares on secondary markets.